NOTE 14 – STOCKHOLDERS’ (DEFICIT) EQUITY

Shares Cancelled

During the six months ended June 30, 2026, the Company cancelled 51,064 shares of Common Stock to satisfy tax withholding obligations related to equity awards.

Warrants

A summary of the Common Stock underlying the warrants activity (including both liability and equity classified instruments) is presented below (in thousands, except number of shares, exercise price, and years data):

A summary of outstanding and exercisable Common Stock underlying the warrants is presented below:

 Second Amended and Restated Sales Agreement

As previously reported, on August 13, 2025, the Company entered into a Sales Agreement (the “Initial Sales Agreement”) with Clear Street LLC (“Clear Street”) to sell from time to time through Clear Street, acting as sales agent for the Company’s “at the market offering” program, shares of the Company’s Common Stock pursuant to the Company’s registration statement on Form S-3 (File No. 333-288194) (the “June Registration Statement”) and the prospectus supplement initially filed on August 13, 2025 (the “Initial Prospectus Supplement”). On August 22, 2025, the Company entered into an Amended and Restated Sales Agreement (the “Amended Sales Agreement”) with Clear Street to, among other things, change the registration statement and prospectus supplement pursuant to which sales of the Common Stock were to be made to the registration statement on Form S-3ASR (File No. 333-289811) (the “WKSI Registration Statement”) and the prospectus supplement initially filed on August 22, 2025 (the “WKSI Prospectus Supplement”). On November 14, 2025, the Company entered into an Amended and Restated Sales Agreement (the “Second Amended Sales Agreement”) with Clear Street and TCBI Securities, Inc., doing business as Texas Capital Securities (“Texas Capital Securities”), and together with Clear Street, the “Agents”), which, among other things, amended and restated the Amended Sales Agreement to include Texas Capital Securities as a sales agent.

On April 8, 2026, the Company entered into the Second Amended and Restated Sales Agreement with the Agents to cease all sales of Common Stock pursuant to the WKSI Registration Statement and WKSI Prospectus Supplement and to transition the program back to the June Registration Statement and Initial Prospectus Supplement. From and after the date of the Second Amended and Restated Sales Agreement, the Company will not sell any Common Stock pursuant to the WKSI Registration Statement and WKSI Prospectus Supplement, and any future sales will be made pursuant to the June Registration Statement and Initial Prospectus Supplement. There were no other material changes to the terms of the Second Amended Sales Agreement as a result of such amendments.

During the six months ended June 30, 2026, the Company sold 1,335,766 shares of Common Stock under the Second Amended and Restated Sales Agreement (the “Second Amended and Restated Sales Agreement”) for net proceeds after fees of approximately $5.17 million at an average price of $3.87 per share. The Company also cancelled 34,886 shares of Common Stock related to tax withholdings on Common Stock awards.

Stock Repurchase Program

During the six months ended June 30, 2026, 7,086,811 shares of Common Stock were repurchased by the Company for $31.3 million in cash (inclusive of fees) under its previously announced stock repurchase program (the “Stock Repurchase Program”), with 3,170 shares remaining in treasury stock as of June 30, 2026.

Second Amended and Restated Sales Agreement with Clear Street

As previously reported, the Company established an “at the market” offering program in August 2025 to sell shares of its Common Stock from time to time through Clear Street LLC (“Clear Street”) as sales agent, pursuant to the Company’s registration statement on Form S-3 (File No. 333-288194) (the “June Registration Statement”) and the related prospectus supplement (the “Initial Prospectus Supplement”). The program was subsequently amended to make sales under the Company’s registration statement on Form S-3ASR (File No. 333-289811) (the “WKSI Registration Statement”) and a related prospectus supplement (the “WKSI Prospectus Supplement”), and to add TCBI Securities, Inc., doing business as Texas Capital Securities, together with Clear Street, as sales agents (the “Agents”).

On April 8, 2026, the Company entered into the Second Amended and Restated Sales Agreement with the Agents to cease all sales of Common Stock pursuant to the WKSI Registration Statement and WKSI Prospectus Supplement and to transition the program back to the June Registration Statement and Initial Prospectus Supplement. From and after the date of the Second Amended and Restated Sales Agreement, the Company will not sell any Common Stock pursuant to the WKSI Registration Statement and WKSI Prospectus Supplement, and any future sales will be made pursuant to the June Registration Statement and Initial Prospectus Supplement. There were no other material changes to the terms of the Second Amended Sales Agreement as a result of such amendments.

During the six months ended June 30, 2026, the Company sold 1,335,766 shares of Common Stock under the Second Amended and Restated Sales Agreement (the “Second Amended and Restated Sales Agreement”) for net proceeds after fees of approximately $5.17 million at an average price of $3.87 per share. The Company also cancelled 34,886 shares of Common Stock related to tax withholdings on Common Stock awards.